288 related articles for article (PubMed ID: 24415871)
1. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
[TBL] [Abstract][Full Text] [Related]
2. ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.
Peretti U; Ferrara R; Pilotto S; Kinspergher S; Caccese M; Santo A; Brunelli M; Caliò A; Carbognin L; Sperduti I; Garassino M; Chilosi M; Scarpa A; Tortora G; Bria E
Respir Res; 2016 Aug; 17(1):105. PubMed ID: 27561692
[TBL] [Abstract][Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication.
Kim MH; Lee S; Koo JS; Jung KH; Park IH; Jeong J; Kim SI; Park S; Park HS; Park BW; Kim JH; Sohn J
PLoS One; 2015; 10(3):e0120320. PubMed ID: 25803816
[TBL] [Abstract][Full Text] [Related]
5. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
[TBL] [Abstract][Full Text] [Related]
6. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.
Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF
World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
[TBL] [Abstract][Full Text] [Related]
10. Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance.
Lin SB; Zhou L; Liang ZY; Zhou WX; Jin Y
J Clin Pathol; 2017 Sep; 70(9):754-759. PubMed ID: 28202495
[TBL] [Abstract][Full Text] [Related]
11. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.
Sukov WR; Hodge JC; Lohse CM; Akre MK; Leibovich BC; Thompson RH; Cheville JC
Mod Pathol; 2012 Nov; 25(11):1516-25. PubMed ID: 22743654
[TBL] [Abstract][Full Text] [Related]
12. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
14. [Copy number aberrations of genes related to extrohepatic metastasis-free survival after operation for hepatocellular carcinoma].
Bao LL; Zhu ZZ; Wen BJ; Wan XX; Ye YQ; Chen L; He SQ; Cong WM
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):349-353. PubMed ID: 28763841
[No Abstract] [Full Text] [Related]
15. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
16. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic lymphoma kinase status in rhabdomyosarcomas.
Yoshida A; Shibata T; Wakai S; Ushiku T; Tsuta K; Fukayama M; Makimoto A; Furuta K; Tsuda H
Mod Pathol; 2013 Jun; 26(6):772-81. PubMed ID: 23307059
[TBL] [Abstract][Full Text] [Related]
20. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
Hu X; He B; Zhou L; Xie H; Zheng S
Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
